Today: 1 July 2026
Browse Category

NASDAQ:IBRX.O 20 January 2026 - 17 May 2026

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio Inc. shares will react Monday to news of a fresh bladder-cancer supply agreement. The company said Saturday it now has exclusive U.S. rights to develop, import and sell the Tokyo-172 BCG strain from Japan BCG Laboratory. ImmunityBio’s main drug Anktiva is already approved to be used with Bacillus Calmette-Guerin, or BCG, for some non-muscle invasive bladder cancers, meaning cancers that haven’t spread into the bladder wall. BCG was first developed as a tuberculosis vaccine but is also given in the bladder to kickstart the immune system against tumors. ImmunityBio said its new Japan deal could bring a second possible U.S. supply of BCG.
17 May 2026
··

Stock Market Today

  • Advit Jewels (NSE:ADVITJEWEL) jumps 36.88% at open after strong IPO demand
    July 1, 2026, 3:04 AM EDT. Shares of Advit Jewels started trading at ₹188.90 on the NSE, up 36.88% from the IPO price of ₹138. On the BSE, the stock opened at ₹187, a 35.51% premium. The IPO saw heavy interest, getting subscribed 212.63 times, led by non-institutional investors at 536.38 times and qualified institutional buyers at 174.98 times. The issue was all fresh shares-1.2 crore-no sale from existing holders. Funds are meant for working capital and repaying ₹65 crore in bank loans. Advit Jewels, founded in 2019 in Jaipur, operates under the Rambhajo label and sells handcrafted fine jewellery in both B2B and B2C channels, mainly in 14K and 18K gold.
Go toTop